Conflicting findings exist on the benefit of withdrawal of inhaled corticosteroid (ICS) in chronic obstructive pulmonary disease (COPD). We performed a quantitative synthesis in order to assess real impact of ICS discontinuation in COPD patients.
Calzetta, L., Matera, M., Braido, F., Contoli, M., Corsico, A., Di Marco, F., et al. (2017). Withdrawal of inhaled corticosteroids in COPD: A meta-analysis. PULMONARY PHARMACOLOGY & THERAPEUTICS, 45, 148-158 [10.1016/j.pupt.2017.06.002].
Withdrawal of inhaled corticosteroids in COPD: A meta-analysis
CALZETTA , LUIGINO;CAZZOLA, MARIO;ROGLIANI, PAOLA
2017-01-01
Abstract
Conflicting findings exist on the benefit of withdrawal of inhaled corticosteroid (ICS) in chronic obstructive pulmonary disease (COPD). We performed a quantitative synthesis in order to assess real impact of ICS discontinuation in COPD patients.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
1-s2.0-S1094553917301256-main.pdf
solo utenti autorizzati
Tipologia:
Versione Editoriale (PDF)
Licenza:
Non specificato
Dimensione
1.31 MB
Formato
Adobe PDF
|
1.31 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
